Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:09 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC N ZVSA | Ionic Ventures LLC | 52,026 4% | 52,026 (New Position) | View |
| 2024-02-14 4:12 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | Anson Funds Management LP | 160,671 9.8% | 160,671 (New Position) | View |
| 2024-02-09 4:04 pm Sale | 13G | ZYVERSA THERAPEUTICS INC ZVSA | L1 Capital Global Opportunities Master Fund Ltd. | 0 0% | -2,034,933 (Position Closed) | View |
| 2024-01-19 06:19 am Sale | 13G | ZYVERSA THERAPEUTICS INC ZVSA | INCON Co. Ltd. | 42,777 3.44% | -1,905,124 (-97.80%) | View |
| 2023-07-18 4:01 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | L1 Capital Global Opportunities Master Fund Ltd. | 2,034,933 8.6% | 2,034,933 (New Position) | View |
| 2023-05-12 2:58 pm Sale | 13D | ZYVERSA THERAPEUTICS INC ZVSA | Glover Stephen C. | 1,420,283 6.76% | -80,991 (-5.39%) | View |
| 2023-05-12 2:55 pm Purchase | 13D | ZYVERSA THERAPEUTICS INC ZVSA | O'Connor Daniel J. | 1,572,303 7.7% | 14,001 (+0.90%) | View |
| 2023-05-03 4:42 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | Ionic Ventures LLC | 2,106,704 9.99% | 2,106,704 (New Position) | View |
| 2023-02-14 5:08 pm Unchanged | 13G | ZYVERSA THERAPEUTICS INC ZVSA | Oaktree Capital Group LLC OAK | 0 0% | 0 (Unchanged) | View |
| 2023-02-14 4:49 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | A.G.P. / ALLIANCE GLOBAL PARTNERS LLC | 849,491 8.9% | 849,491 (New Position) | View |
| 2023-02-14 11:20 am Sale | 13G | LARKSPUR HEALTH ACQ CORP UNIT LSPRU | Lighthouse Investment Partners LLC | 0 0% | -512,176 (Position Closed) | View |
| 2023-02-14 06:05 am Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | INCON Co. Ltd. | 1,947,901 16.49% | 1,947,901 (New Position) | View |
| 2023-02-09 2:30 pm Unchanged | 13G | ZYVERSA THERAPEUTICS INC ZVSA | Hudson Bay Capital Management LP | 0 0% | 0 (Unchanged) | View |
| 2023-01-31 09:11 am Sale | 13G | LARKSPUR HEALTH ACQ CORP UNIT LSPRU | Yakira Capital Management Inc. | 0 0% | -512,176 (Position Closed) | View |
| 2023-01-13 3:11 pm Purchase | 13G | ZYVERSA THERAPEUTICS INC ZVSA | Titcomb Shawn | 874,698 9.63% | 874,698 (New Position) | View |
| 2022-12-22 5:30 pm Purchase | 13D | ZYVERSA THERAPEUTICS INC ZVSA | Glover Stephen C. | 1,501,274 15.1% | 1,501,274 (New Position) | View |
| 2022-12-22 5:29 pm Purchase | 13D | ZYVERSA THERAPEUTICS INC ZVSA | O'Connor Daniel J. | 1,558,302 16.8% | 1,558,302 (New Position) | View |
| 2022-03-11 09:06 am Purchase | 13G | LARKSPUR HEALTH ACQ CORP UNIT LSPRU | Saba Capital Management L.P. | 474,280 6.1% | 474,280 (New Position) | View |
| 2022-02-14 12:00 pm Purchase | 13G | LARKSPUR HEALTH ACQ CORP UNIT LSPRU | Lighthouse Investment Partners LLC | 512,176 5.28% | 512,176 (New Position) | View |
| 2022-02-09 10:37 am Purchase | 13G | LARKSPUR HEALTH ACQ CORP UNIT LSPRU | Yakira Capital Management Inc. | 512,176 6.55% | 512,176 (New Position) | View |